Delivery Order SPE2DB22D3501-SPE2DB24FUV63
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a potential value of $5,674.44 and a completion date of February 7, 2024. This delivery order does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this award, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,147.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,107,023 units of RUXIENCE 500 MG/50 ML VIAL 50ML, with a period of performance through March 29, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $4,728.70 contract is for the delivery of RUXIENCE 500 MG/50 ML vial medication with an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a $19,118.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has a ceiling value of $4,266.10 and is a firm-fixed-price delivery order, with a completion date of May 30, 2025. The contract is not set aside for any small business program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,796.78 order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,913.72 firm fixed-price contract is for the delivery of the medication RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of July 3, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 500 mg/50 ml vials of the pharmaceutical RUXIENCE. The $2,837.28 contract has a performance period through January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value up to $999,999,999.00 through December 31, 2025, which...
- This is a $53,734.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of September 10, 2024 and is not set aside for any specific business type. AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999, to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $9,457.40 contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUV63Delivery Order
The Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $5,013.96 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,894,444 units of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract is a firm fixed price arrangement with a completion date of March 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. Additionally, AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025, to provide a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 3/7/24 |